AntibodySystem는 Primary Antibody Biosimilar - Research Grade
제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.
제품 설명
Research Grade Solanezumab
제품 번호
DHC12505
제품 특징
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the Aβ peptide. It recognizes soluble monomeric, not fibrillar, Aβ. Solanezumab (formerly known as LY2062430) is a monoclonal antibody being developed by Lilly as a potential therapy for people with mild cognitive impairment caused by Alzheimer’s disease.
XtenCHO
Human
Humanized
IgG1-kappa
Monoclonal
AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50
1.8 mg/ml
Please contact with the lab for this information.
>95% by SDS-PAGE.
Protein A/G purified from cell culture supernatant.
Research Grade Biosimilar
Liquid
0.01M PBS, pH 7.4.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
LY2062430, CAS: 955085-14-0
Data Image
AntibodySystem의 모든 제품들을 만나 보세요!
{ const originalImageSrc = iconImages[index].src; li.addEventListener('mouseenter', () => { iconImages[index].src = originalImageSrc.replace('.png', '_w.png'); }); li.addEventListener('mouseleave', () => { iconImages[index].src = originalImageSrc; }); }); function goBack(){ window.history.back(); }